Skip to main content
myCVS ®

43930 FARMWELL HUNT PLAZA, UNIT 140, ASHBURN, VA 20147

Weekly Ad
Back to Store Details

COVID-19 Vaccine at
1059 Hyde St., San Francisco, CA 94109

CVS Health offers COVID-19 Vaccines. Limited appointments now available for patients who qualify.

CVS Health administered more than 32 million COVID-19 tests and more than 59 million COVID-19 vaccines in 2021. The Company maintains a strong commitment to vaccine and testing equity and continues to optimize site locations and targeted outreach initiatives in order to reach vulnerable populations.

Following guidelines set by ACIP and the CDC, all individuals who are 5 years of age and older are eligible to receive a single age-appropriate COVID-19 booster shot. Additional recommendations based on age and primary vaccination series are as follows.

  • Non-immunocompromised patients aged 5 years old and above who received a Pfizer-BioNTech COVID-19 primary vaccine series are eligible for a first booster at least five months after the second primary series dose.

  • Non-immunocompromised patients aged 18 years old and above who received a Moderna COVID-19 primary vaccine series are eligible for a first booster at least five months after the second primary series dose.

  • Patients aged 18 years old and above who received a Johnson & Johnson (Janssen) COVID-19 vaccine dose are eligible for a first booster at least two months after their last primary vaccine dose.

  • Immunocompromised patients who received a Pfizer-BioNTech (12 years old and above) or Moderna (18 years old and above) three-dose primary series (including an additional dose) are eligible for a booster at least three months after their primary vaccine series.

  • Immunocompromised patients aged 5 to 11 years of age who received a Pfizer-BioNTech three-dose primary series (including an additional dose) are eligible for a booster at least five months after their primary vaccine series.

Eligible individuals do not need to receive a booster shot that matches the formulation of their primary series. Please refer to the CDC Interim Clinical Considerations for COVID-19 Vaccines or your healthcare provider for manufacturer and dose-specific guidance.

As of November 19, the Pfizer-BioNTech and Moderna COVID-19 vaccines boosters are authorized for eligible individuals age 18 and above, following FDA authorization, and under guidelines set by ACIP and the CDC.

On December 9, the FDA and CDC authorized the administration of a booster dose of the Pfizer-BioNTech vaccine for patients ages 16-17 years, six months after receiving the second dose of their primary COVID-19 vaccination series.

Additionally, individuals who are 18 years and older and received the Johnson & Johnson (Janssen) COVID-19 vaccine may receive a single booster dose of Johnson & Johnson (Janssen), Moderna, or Pfizer-BioNTech COVID-19 vaccine at least two months after receiving their primary vaccination.

CVS Pharmacy will provide Moderna or Pfizer-BioNTech vaccine booster shots to eligible individuals who received the Johnson & Johnson (Janssen) vaccine as their primary vaccination. CVS Pharmacy will not be offering booster shots of the Johnson & Johnson (Janssen) vaccine.

Moderna booster shots for eligible individuals 18+ and Pfizer-BioNTech booster shots for eligible individuals 5+ are available at select CVS Pharmacy and MinuteClinic locations.

A parent or legal guardian must complete the online registration on CVS.com or Minuteclinic.com for minors up to age 17. Teens 16 and older do not need to be accompanied by an adult to their vaccination appointment unless required by local or state law.

Yes, the booster is available at no cost to any eligible patient with most insurance plans or for those uninsured.

Patients interested in receiving the Pfizer-BioNTech or Moderna COVID-19 booster are strongly encouraged to make an appointment at CVS.com or MinuteClinic.com . Advanced scheduling is recommended for patients looking to receive a COVID-19 vaccine from a specific manufacturer to ensure that it is available at the clinic of their choice. At this time, each participating CVS Pharmacy or MinuteClinic is offering either the Pfizer-BioNTech or the Moderna vaccine. Same-day or walk-in vaccination appointments may be possible but are subject to local demand.

Yes. According to the CDC, eligible individuals, including children, may receive the seasonal flu vaccine at the same time they are receiving the Pfizer-BioNTech or Moderna COVID-19 vaccine. There is no need to stagger vaccinations. Additionally, if an individual has already received a flu shot, they can receive their COVID-19 vaccine at any time.

The Delta variant causes more infections and spreads faster than the original SARS-CoV-2 strain of the virus that causes COVID-19. The Omicron variant likely will spread more easily than the original SARS-CoV-2 virus, but how easily Omicron spreads compared to Delta remains unknown. The CDC expects that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms.

Vaccines remain the best way to reduce your risk of severe illness, hospitalization, and death from COVID-19. Current vaccines are expected to protect against severe illness, hospitalizations, and deaths due to infection with the Omicron variant. However, breakthrough infections in people who are fully vaccinated are likely to occur. With other variants, like Delta, vaccines have remained effective at preventing severe illness, hospitalizations, and death. The recent emergence of Omicron further emphasizes the importance of vaccination and boosters.

Masks offer protection against all variants. CDC continues to recommend wearing a mask in public indoor settings in areas of substantial or high community transmission , regardless of vaccination status.

For more information, visit the CDC’s page on variants .

The FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines. As of August 23, 2021, the FDA has issued full approval of the Pfizer-BioNTech vaccine for ages 16+.

The previously issued Emergency Use Authorizations (EUA) for the Pfizer-BioNTech vaccine for those ages 12 to 15 and third doses for the immunocompromised, as well as EUAs for COVID-19 vaccines manufactured by Moderna and Johnson & Johnson's Janssen, remain in effect. An EUA gives the FDA authority to allow unapproved medical products to be used in emergencies when no approved alternatives are available. Other COVID-19 vaccines are in development and will be reviewed by the FDA under EUA. Find the current status of the vaccine approvals and EUAs.